Publications by authors named "Chizuko Hashimoto"

Claim this Profile
D
Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma.
Masahiro Akimoto, Takuya Miyazaki, Hiroyuki Takahashi, Takaaki Takeda, Yuto Hibino, Chizuko Hashimoto

Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
Takayoshi Tachibana, Akihiko Izumi, Shota Arai, Takaaki Takeda, Natsuki Hirose, Chizuko Hashimoto

Exp Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world toxicity and efficacy of asciminib in heavily pretreated patients with chronic myeloid leukemia.
Yoshimi Ishii, Shin Fujisawa, Takuya Miyazaki, Yuki Nakajima, Ayako Matsumura, Chizuko Hashimoto

Int J Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
Shota Arai, Takayoshi Tachibana, Akihiko Izumi, Takaaki Takeda, Yotaro Tamai, Chizuko Hashimoto

Int J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio.
Takuya Miyazaki, Takayoshi Tachibana, Taisei Suzuki, Akihiko Izumi, Katsumichi Fujimaki, Chizuko Hashimoto

Transplant Cell Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.
Masahiro Akimoto, Takuya Miyazaki, Hiroyuki Takahashi, Yusuke Saigusa, Takaaki Takeda, Chizuko Hashimoto

Int J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study.
Hiroyuki Takahashi, Rika Sakai, Takayuki Sakuma, Ayako Matsumura, Kazuho Miyashita, Chizuko Hashimoto

Indian J Hematol Blood Transfus· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia.
Taiki Ando, Shin Fujisawa, Haruka Teshigawara, Eriko Ogusa, Yoshimi Ishii, Chizuko Hashimoto

Int J Hematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study.
Takayoshi Tachibana, Taiki Andou, Masatsugu Tanaka, Satomi Ito, Takuya Miyazaki, Chizuko Hashimoto

Clin Lymphoma Myeloma Leuk· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.
Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Chizuko Hashimoto

Leuk Lymphoma· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
Taiki Ando, Etsuko Yamazaki, Eriko Ogusa, Yoshimi Ishii, Wataru Yamamoto, Chizuko Hashimoto

Int J Hematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.
Naoto Tomita, Taisei Suzuki, Kazuho Miyashita, Wataru Yamamoto, Kenji Motohashi, Chizuko Hashimoto

Leuk Lymphoma· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.
Yoshimi Ishii, Naoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, Kumiko Kishimoto, Chizuko Hashimoto

Leuk Lymphoma· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.
Naoto Tomita, Masataka Taguri, Chizuko Hashimoto, Hirotaka Takasaki, Katsumichi Fujimaki

Ann Hematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-treatment PET-CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass.
Hirotaka Takasaki, Wataru Yamamoto, Yoshimi Ishii, Hiroyuki Takahashi, Reina Watanabe, Chizuko Hashimoto

Indian J Hematol Blood Transfus· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy.
Kazuho Miyashita, Naoto Tomita, Masataka Taguri, Taisei Suzuki, Yasufumi Ishiyama, Chizuko Hashimoto

Leuk Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-CHOP therapy alone for limited-stage follicular lymphoma.
Naoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, Kazuho Miyashita, Hiroyuki Takahashi, Chizuko Hashimoto

Leuk Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy].
Hideyuki Koharazawa, Reina Watanabe, Yukako Hattori, Ayumi Numata, Rika Kawasaki, Chizuko Hashimoto

Rinsho Ketsueki· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Naoto Tomita, Fumio Kodama, Naoko Tsuyama, Seiji Sakata, Kengo Takeuchi, Chizuko Hashimoto

Hematol Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
Naoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, Kumiko Kishimoto, Daisuke Ishibashi, Chizuko Hashimoto

Leuk Lymphoma· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-therapy ¹⁸F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma.
Naoto Tomita, Yukako Hattori, Shin Fujisawa, Chizuko Hashimoto, Jun Taguchi

Ann Hematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy.
Yuki Nakajima, Naoto Tomita, Megumi Itabashi, Kazuho Miyashita, Reina Watanabe, Chizuko Hashimoto

Leuk Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy.
Yuki Nakajima, Naoto Tomita, Reina Watanabe, Yasufumi Ishiyama, Eri Yamamoto, Chizuko Hashimoto

Med Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Reina Watanabe, Naoto Tomita, Megumi Itabashi, Daisuke Ishibashi, Eri Yamamoto, Chizuko Hashimoto

Eur J Haematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients.
Eri Yamamoto, Shin Fujisawa, Maki Hagihara, Masatsugu Tanaka, Katsumichi Fujimaki, Chizuko Hashimoto

Cancer Sci· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis